ACP-204 in Adults With Alzheimer's Disease Psychosis Open Label Extension Study
NCT ID: NCT06194799
Last Updated: 2026-02-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
PHASE3
752 participants
INTERVENTIONAL
2024-04-23
2029-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
ACP-204 in Adults With Alzheimer's Disease Psychosis
NCT06159673
Phase 3, Open Label Extension Study of ACP-204 in Lewy Body Dementia Psychosis
NCT07095465
ACP-104 in Acutely Psychotic Subjects With Schizophrenia
NCT00490516
Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis
NCT07029581
Safety and Efficacy Study for Cognitive Deficits in Adult Subjects With Schizophrenia
NCT01095562
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ACP-204
ACP-204 30mg or 60mg
ACP-204
ACP-204 30 mg given once daily, as capsule OR ACP-204 60 mg given once daily, as capsule
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ACP-204
ACP-204 30 mg given once daily, as capsule OR ACP-204 60 mg given once daily, as capsule
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Male or female (age 55 to 95 years old): female must be of non-childbearing potential, male must take appropriate contraceptive method if partner has childbearing potential
* Subject has a designated study partner/caregiver
* Subjects are able to complete all study visits with a study partner/caregiver
* Signed inform consent form with a caregiver or legal representative
Exclusion Criteria
* Is in hospice and receiving end-of-life palliative care, or has become bedridden
* Unstable clinically significant medical condition other than AD
* Any medical condition that in the opinion of the investigator may affect safety or ability to complete the study
55 Years
95 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
ACADIA Pharmaceuticals Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
ATP Clinical Research
Costa Mesa, California, United States
New Life Medical Research Center
Hialeah, Florida, United States
Reliable Clinical Research LLC
Hialeah, Florida, United States
Homestead Associates in Research Inc.
Miami, Florida, United States
Premier Clinical Research Institute Inc
Miami, Florida, United States
Advanced Clinical Research
Miami, Florida, United States
Verus Clinical Research
Miami, Florida, United States
Future Care Solution, LLC
Miami, Florida, United States
MediClear Medical & Research Center, Inc.
Miami, Florida, United States
ABBA Medical Research LLC
Miami, Florida, United States
New Med Research
Miami Gardens, Florida, United States
Floridian Neuroscience Institute
Miami Lakes, Florida, United States
Abington Neurological Associates
Abington, Pennsylvania, United States
Uni Texas Health Science Center
Houston, Texas, United States
Clinical Trial Network LLC
Houston, Texas, United States
Hospital Moinhos de Vento
Porto Alegre, Rio Grande do Sul, Brazil
Hospital Universitario de Brasilia
Brasília, , Brazil
TrialTech Tecnologia com Pesquisas em Medicamentos
Curitiba, , Brazil
Inst de Neurologia de Curitiba Hospital Ecoville
Curitiba, , Brazil
Instituto Mederi de Pesquisa e Saude
Passo Fundo, , Brazil
Ruschel Medicina e Pesquisa Clínica
Rio de Janeiro, , Brazil
Facili - Centro Integrado de Psiquiatria
São Bernardo do Campo, , Brazil
BR Trials-Ensaios Clinicos e Consultoria
São Paulo, , Brazil
ET Dr. Ivo Natsov-AIPSMC in Psychiatry
Cherven Bryag, , Bulgaria
Medical Center Lifemed
Kardzhali, , Bulgaria
DCC Higia
Pazardzhik, , Bulgaria
Medical center Medconsult Pleven OOD
Pleven, , Bulgaria
Mental Health Centre-Prof. N Shipkovenski EOOD
Sofia, , Bulgaria
DCC St. Vrach and St. St. Kuzma and Damian OOD
Sofia, , Bulgaria
UMHAT Alexandrovska EAD
Sofia, , Bulgaria
Psicomed Estudios Medicos
Antofagasta, , Chile
Biomedica Research Group
Santiago, , Chile
Especialidades Medicas L y S
Santiago, , Chile
CIC de la Universidad Catolica CICUC
Santiago, , Chile
Fakultni nemocnice u sv. Anny v Brne
Brno, , Czechia
BRAIN-SOULTHERAPY s.r.o
Kladno, , Czechia
AD71 s.r.o
Prague, , Czechia
Clinical s.r.o
Prague, , Czechia
Vestra Clinics s.r.o.
Rychnov nad Kněžnou, , Czechia
Hôpital Lariboisière
Paris, , France
Hôpital La Grave
Toulouse, , France
ASST Spedali Civili di Brescia
Brescia, , Italy
Azienda Ospedaliera Universitaria OO. RR. S
Salerno, , Italy
Hospital Universitario Dr. Jose Eleuterio Gonzalez
Monterrey, Neuvo Leon, Mexico
Iecsi S.C.
Monterrey, Nuevo León, Mexico
Neurociencias Estudios Clinicos
Culiacán, Sinaloa, Mexico
Centro para el Des de la Med y de Asist Med Esp SC
Culiacán, Sinaloa, Mexico
Hospital Universitario de Saltillo
Coahuila, , Mexico
BIND Investigaciones S.C.
San Luis Potosí City, , Mexico
Clinical Center Dr Dragisa Misovic Dedinje
Belgrade, , Serbia
Special Hospital for Psychiatric Diseases
Gornja Toponica, , Serbia
Special Hospital for Psychiatric Diseases Kovin
Kovin, , Serbia
Jovanovic University Clinical Centre of Kragujevac
Kragujevac, , Serbia
Petrovic University Clinical Center Kragujevac
Kragujevac, , Serbia
University Clinical Center Nis
Niš, , Serbia
The Catholic University of Korea
Seoul, Republic of Korea, South Korea
Inha University Hospital
Incheon, , South Korea
Hanyang University Seoul Hospital
Seoul, , South Korea
Samsung Medical Center
Seoul, , South Korea
Seoul National University Boramae Medical Center
Seoul, , South Korea
Hospital Universitario Virgen Macarena
Seville, , Spain
Hospital Provincial de Zamora
Zamora, , Spain
Kaohsiung Municipal Ta-Tung Hospital
Kaohsiung City, , Taiwan
Kaohsiung Medical University Chung-Ho Memorial Hospital
Kaohsiung City, , Taiwan
E-DA Hospital
Kaohsiung City, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Luminous
Identifier Type: OTHER
Identifier Source: secondary_id
ACP-204-008
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.